<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19969" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Obstructive Pulmonary Disease Compensatory Measures</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pahal</surname>
            <given-names>Parul</given-names>
          </name>
          <aff>ISMMS Mount Sinai Hospital, NYC, NY</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Parul Pahal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19969.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>According to epidemiological data, chronic obstructive pulmonary disease (COPD) is expected to be the third leading cause of death. Although the prognosis of affected patients is improving with new treatment modalities, the mortality in these patients is still high. Tobacco smoking accounts for most cases of COPD in developed nations. However, in developing countries, environmental pollutants are the major cause of COPD. Nearly 90% of COPD-related mortality among individuals younger than 70 years of age occurs in low- and middle-income countries. This activity reviews the causes of COPD, the options for evaluation, treatment, and prevention, and discusses the role of the interprofessional team in managing and educating patients with COPD.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the association between tobacco use and chronic obstructive pulmonary disease.</p></list-item><list-item><p>Describe the association between environmental pollution and chronic obstructive pulmonary disease.</p></list-item><list-item><p>Summarize how acid-base disorders influence chronic obstructive pulmonary disease.</p></list-item><list-item><p>Review the compensatory mechanisms that can occur in chronic obstructive pulmonary disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19969&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19969">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19969.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>According to epidemiological data, chronic&#x000a0;obstructive pulmonary&#x000a0;disease (COPD) is expected to be the third leading cause of death.<xref ref-type="bibr" rid="article-19969.r1">[1]</xref>&#x000a0;Although the prognosis of these patients is improving with new treatment modalities,&#x000a0;the mortality in these patients is still high.<xref ref-type="bibr" rid="article-19969.r2">[2]</xref><xref ref-type="bibr" rid="article-19969.r3">[3]</xref></p>
        <p>Tobacco smoking accounts for most cases of COPD in developed nations. The severity of the disease depends on the number of pack-years smoked and the duration of smoking, leading to progressive lung function loss due to alveolar damage. However, in developing countries, environmental pollutants are the major cause of COPD. Nearly 90% of COPD-related&#x000a0;mortality among individuals younger than 70 years of age&#x000a0;occurs in low- and middle-income countries (LMIC).<xref ref-type="bibr" rid="article-19969.r4">[4]</xref>&#x000a0;This increased mortality in LMIC is due to the use of&#x000a0;biomass fuel to generate energy modes.<xref ref-type="bibr" rid="article-19969.r5">[5]</xref><xref ref-type="bibr" rid="article-19969.r6">[6]</xref>&#x000a0;Specifically, residues from the&#x000a0;agricultural crop and firewood are the commonly used biomass fuel. Due to the burning of biomass fuel, there are toxic fumes in the air in the form of particulate matter consisting of carbon monoxide, polyaromatic and poly-organic hydrocarbons, and formaldehyde.</p>
        <p>Many COPD patients develop acute exacerbation and are admitted to intensive care units (ICU). Many factors affect the outcome, and one of the most important factors is the&#x000a0;acid-base disorder in COPD patients. The function and clinical significance of COPD are discussed in this review article. The&#x000a0;natural history, diagnosis, prognosis, and treatment of COPD are discussed&#x000a0;in another article.&#x000a0;</p>
      </sec>
      <sec id="article-19969.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Compensation by the Body in Patients with COPD</bold>
</p>
        <p>
<bold>Acute or Chronic Hypoxia in COPD Patients</bold>
</p>
        <p>Maintenance of ventilation-perfusion ratio by compensatory pulmonary vasoconstriction:&#x000a0;In COPD, the acute change that occurs immediately secondary to hypoxia is hypoxic pulmonary vasoconstriction. Alveolar dead space in COPD leads to inefficient gas exchange and a ventilation-perfusion mismatch. Therefore, the body tries to maintain the V/Q ratio by localized vasoconstriction in the affected lung areas that are not oxygenated well.<xref ref-type="bibr" rid="article-19969.r7">[7]</xref><xref ref-type="bibr" rid="article-19969.r8">[8]</xref></p>
        <p>As COPD advances, these patients cannot maintain a&#x000a0;normal respiratory exchange. COPD patients have a reduced ability to exhale carbon dioxide adequately, which leads to hypercapnia.<xref ref-type="bibr" rid="article-19969.r9">[9]</xref><xref ref-type="bibr" rid="article-19969.r10">[10]</xref>&#x000a0;Over time, chronic elevation of carbon dioxide leads to acid-base disorders and a shift of normal respiratory drive to hypoxic drive.</p>
        <p>Hypercapnia and shift of normal respiratory drive to hypoxic drive&#x000a0;to maintain respiratory hemostasis: Carbon dioxide is the main stimulus for the&#x000a0;respiratory drive in normal physiological states. Carbon dioxide increases the hydrogen ions, which lowers the pH. Chemoreceptors are more sensitive to alteration in acid-base balance. An increase in arterial carbon dioxide levels indirectly stimulates central chemoreceptors (medulla oblongata) and directly stimulates peripheral chemoreceptors (carotid bodies and aortic arch). Chemoreceptors are less responsive to oxygen levels. In COPD patients, this effect is blunted as the chemoreceptors develop tolerance to chronically elevated arterial carbon dioxide levels. This is when the normal respiratory drive shifts to hypoxic drive and the low oxygen level play a pivotal role in the stimulation of respiration through the chemoreceptors and maintaining respiratory hemostasis. That is why the target pulse oximetry in these patients is 88% to 92%.<xref ref-type="bibr" rid="article-19969.r11">[11]</xref><xref ref-type="bibr" rid="article-19969.r12">[12]</xref></p>
        <p>Renal compensation&#x000a0;to maintain near-normal pH in COPD patients:&#x000a0;The lungs and the kidneys are the key organs responsible for keeping&#x000a0;the body&#x02019;s pH in balance. In COPD patients, kidneys compensate by retaining bicarbonate to neutralize pH.<xref ref-type="bibr" rid="article-19969.r13">[13]</xref></p>
        <p>
<bold>Renal Compensation in COPD Patients to Maintain Acid-base Balance</bold>
</p>
        <p>The ph and the hydrogen ions concentration are determined by the ratio of bicarbonate/pCO2 and not by any single value, and the Hasselbach equation can explain this.</p>
        <list list-type="bullet">
          <list-item>
            <p>pH = 6.1 + log &#x02212; HCO3/0.03pCO2</p>
          </list-item>
        </list>
        <p>The metabolic disorders and respiratory disorders lead to alteration in bicarbonate and pCO2, respectively. The body tries to maintain and minimize changes in the pH by&#x000a0;activating&#x000a0;the compensatory mechanisms to keep the bicarbonate/pCO2 ratio constant. The compensation can be predicted to some extent based on primary metabolic or respiratory disorders.</p>
        <p>In COPD patients, chronically elevated carbon dioxide shifts the normal acid-base balance toward acidic.<xref ref-type="bibr" rid="article-19969.r14">[14]</xref>&#x000a0;There is the retention of carbon dioxide, which is hydrated to form carbonic acid. Carbonic acid is a weak and volatile acid that quickly dissociates to form hydrogen and bicarbonate ions&#x000a0;resulting in respiratory acidosis. This primary event is characterized by increased pCO2 and a fall in pH on arterial blood gas analysis.</p>
        <p>The response to acute and chronic respiratory acidosis is not to the same extent as both phases have different compensatory mechanisms.&#x000a0;In acute hypercapnia, only 1 mEq of bicarbonate increases with every 10 mm Hg increase in pCO2. H+ ions buffering in the acute phase occurs&#x000a0;via proteins (primarily hemoglobin) and other buffers (non-bicarbonate).</p>
        <list list-type="bullet">
          <list-item>
            <p>H2CO3+ &#x02212;Hb =&#x0003e; HHb + &#x02212;HCO3</p>
          </list-item>
        </list>
        <p>The body has a mechanism to adapt to adversities. Adjusting the pH by the kidneys is much more effective in chronic respiratory acidosis and can be better tolerated than in the acute phase. In COPD patients with comorbidities, mixed acid-base disorders can be seen.<xref ref-type="bibr" rid="article-19969.r15">[15]</xref></p>
        <p>The body tries to compensate for chronic respiratory acidosis in COPD patients by retaining more bicarbonate to overcome acidosis. The renal compensation sets in, and the kidneys adapt&#x000a0;to excrete carbon dioxide in the form of carbonic acid and reabsorb more bicarbonate. It usually takes about 3 to 5 days for the maximum response. This helps maintain acid-base balance near normal and prevents the pH from becoming dangerously low.<xref ref-type="bibr" rid="article-19969.r16">[16]</xref></p>
        <p>However, this effect is only at the blood level, not the brain. So, in long-term illness causing respiratory acidosis,&#x000a0;central nervous systems (CNS) symptoms such as headache, anxiety, sleep disturbance, and drowsiness can be seen.<xref ref-type="bibr" rid="article-19969.r17">[17]</xref></p>
      </sec>
      <sec id="article-19969.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>COPD Patients with Renal Failure and Acute COPD Exacerbation&#x000a0;</bold>
</p>
        <p>The&#x000a0;kidneys cannot reabsorb bicarbonate in these patients to compensate for chronic respiratory acidosis. Over time, mixed respiratory and metabolic acidosis sets in, causing dangerously low pH levels. The mortality rate is much higher in these patients.</p>
        <p>In addition, low pH can lead to harmful effects on the heart. Low pH causes heart muscle and heart rhythm dysfunction, which predisposes these patients to arrhythmias. In addition, it can also cause a&#x000a0;drop in blood pressure. However, acute Hypercapnia per se due to&#x000a0;acute COPD exacerbation does not predict increased mortality. In contrast, chronic Hypercapnia has been shown to lead to a decreased five-year survival.<xref ref-type="bibr" rid="article-19969.r18">[18]</xref></p>
        <p>
<bold>Cautious use of Supplemental Oxygen to Prevent Hypercapnia&#x000a0;</bold>
</p>
        <p>There is emerging evidence to support conservative administration of O2 (to achieve O2 saturation between 88-94%), particularly in patients hospitalized for COPD exacerbation.<xref ref-type="bibr" rid="article-19969.r19">[19]</xref><xref ref-type="bibr" rid="article-19969.r20">[20]</xref>
</p>
        <p>In patients with COPD, oxygen treatment can lead to an acute increase in CO2, but the effect of O2 on the hypoxic ventilatory drive is relatively small.<xref ref-type="bibr" rid="article-19969.r21">[21]</xref>&#x000a0;The rise in CO2 is mainly due to VQ mismatch&#x000a0;leading to increased dead space.<xref ref-type="bibr" rid="article-19969.r22">[22]</xref> The Haldane effect&#x000a0;also contributes to the rise of CO2 but to a lesser degree.</p>
      </sec>
      <sec id="article-19969.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Prognosis</bold>
</p>
        <p>Acidosis and comorbidities in COPD patients are poor prognostic indicators. At low pH, intubation and mortality rates are higher. Comorbidities,&#x000a0;especially renal failure in COPD, have a worse prognosis as the kidneys fail to compensate effectively, resulting in severe acidosis in these patients and a lesser increase in bicarbonate level.<xref ref-type="bibr" rid="article-19969.r23">[23]</xref><xref ref-type="bibr" rid="article-19969.r24">[24]</xref></p>
        <p>
<bold>Prevention of Hypercarbia-Related Complications in COPD Patients</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Careful monitoring and proper management of COPD</p>
          </list-item>
          <list-item>
            <p>Smoking cessation</p>
          </list-item>
          <list-item>
            <p>A healthy lifestyle and regular exercise help prevent diseases that can worsen respiration.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19969.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>COPD is a complex disease and a cause of significant morbidity and mortality. It requires interprofessional care and the involvement of more than one subspecialty to create a healthcare team. This patient-centered&#x000a0;approach involving a physician with a team of other health professionals, physiotherapists, respiratory therapists, dieticians, social workers, clinical psychologists, nurses, and support groups working together for&#x000a0;the patient plays a vital role in improving the quality of care in COPD patients. It not only decreases the hospital admission rates but also positively affects the disease outcome.</p>
        <p>Based on the symptoms and smoking history, the family physician orders spirometry to determine the diagnosis and assess the disease's severity. The comorbidities and infections are common causes of worsening COPD and COPD exacerbation. Therefore, properly monitoring and managing COPD and its comorbidities are equally crucial in improving the survival&#x000a0;of COPD patients. The patients with severe diseases who experience exacerbations are managed in the respiratory unit ICU. COPD exacerbation in patients with kidney disease needs to be treated in the ICU, where they can be taken care of by the different subspecialty physicians. On discharge, the&#x000a0;collaboration between the hospital and the family physician ensures the&#x000a0;continuous maintenance of the patient.</p>
        <p>The complex management of COPD involves patient education, self-management, and pulmonary rehabilitation in addition to the above. Physicians and respiratory&#x000a0;therapists assist with patient education, which primarily includes behavior/lifestyle modification, for example, smoking cessation, education about symptoms of COPD exacerbation, the&#x000a0;importance&#x000a0;of regular medications, and the proper use of prescribed medications. Self-management plan includes taking medications regularly, awareness of severe symptoms, and learning to live with the disease.</p>
        <p>Pulmonary rehabilitation is also necessary to improve dyspnea and exercise tolerance and substantially reduce hospital admission rates. A physiotherapist can assist in pulmonary rehabilitation programs to help with exercise and overall conditioning. The nurse can assist with patient monitoring, education, and follow-up care coordination. The pharmacist can help avoid drug-drug interactions and make recommendations regarding appropriate therapy and dosing. Dieticians&#x000a0;can assist patients who are overweight or underweight. Family physicians play an important role in discussing end-of-life and palliative care with the patients.</p>
        <p>The communication between the interprofessional team members&#x000a0;caring for the patient, accurate documentation of the patient's status, and regular assessment of the patient's condition helps maximize the respiratory&#x000a0;potential of the patient and, hence cost-effectively decreases the disease burden.<xref ref-type="bibr" rid="article-19969.r25">[25]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-19969.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19969&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19969">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19969/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19969">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19969.s8">
        <title>References</title>
        <ref id="article-19969.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pahal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Avula</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Emphysema</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29489292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ansari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Understanding the Impact of Chronic Obstructive Pulmonary Disease and Intervening to Improve Self-Management in the Context of Multi-morbidity.</article-title>
            <source>Int J Integr Care</source>
            <year>2018</year>
            <month>Jul</month>
            <day>19</day>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>7</fpage>
            <pub-id pub-id-type="pmid">30093845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheradmand</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hee Gu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Corry</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema.</article-title>
            <source>Trans Am Clin Climatol Assoc</source>
            <year>2017</year>
            <volume>128</volume>
            <fpage>222</fpage>
            <page-range>222-233</page-range>
            <pub-id pub-id-type="pmid">28790504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddharthan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Quaderi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rykiel</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Wosu</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Alupo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>C&#x000e1;rdenas</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chandyo</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Flores-Flores</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kirenga</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ricciardi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Checkley</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JR</given-names>
              </name>
              <collab>GECo Study Investigators</collab>
            </person-group>
            <article-title>Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Jan</month>
            <day>11</day>
            <volume>327</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-160</page-range>
            <pub-id pub-id-type="pmid">35015039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicolini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barbagelata</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tagliabue</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Monacelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Braido</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Gender differences in chronic obstructive pulmonary diseases: a narrative review.</article-title>
            <source>Panminerva Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>192</fpage>
            <page-range>192-199</page-range>
            <pub-id pub-id-type="pmid">29856178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Somda</surname>
                <given-names>SMA</given-names>
              </name>
              <name>
                <surname>Meda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bouland</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis.</article-title>
            <source>BMJ Open Respir Res</source>
            <year>2018</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>e000246</fpage>
            <pub-id pub-id-type="pmid">29387422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagaraj</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tabeling</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Papp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pienn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Witzenrath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghanim</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klepetko</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Weir</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Heschl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kwapiszewska</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Olschewski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olschewski</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28729471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunham-Snary</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sykes</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Thakrar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>LRG</given-names>
              </name>
              <name>
                <surname>Mewburn</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine.</article-title>
            <source>Chest</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-192</page-range>
            <pub-id pub-id-type="pmid">27645688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viniol</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vogelmeier</surname>
                <given-names>CF</given-names>
              </name>
            </person-group>
            <article-title>Exacerbations of COPD.</article-title>
            <source>Eur Respir Rev</source>
            <year>2018</year>
            <month>Mar</month>
            <day>31</day>
            <volume>27</volume>
            <issue>147</issue>
            <pub-id pub-id-type="pmid">29540496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Respiratory load compensation during hypercapnic ventilatory response in pulmonary emphysema.</article-title>
            <source>Chest</source>
            <year>1994</year>
            <month>May</month>
            <volume>105</volume>
            <issue>5</issue>
            <fpage>1399</fpage>
            <page-range>1399-405</page-range>
            <pub-id pub-id-type="pmid">8181326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inkrott</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Understanding Hypoxic Drive and the Release of Hypoxic Vasoconstriction.</article-title>
            <source>Air Med J</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>210</fpage>
            <page-range>210-1</page-range>
            <pub-id pub-id-type="pmid">27393755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Donnell</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Banzett</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Carrieri-Kohlman</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Casaburi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Gandevia</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Gelb</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Mahler</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.</article-title>
            <source>Proc Am Thorac Soc</source>
            <year>2007</year>
            <month>May</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-68</page-range>
            <pub-id pub-id-type="pmid">17494725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ucgun</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Oztuna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dagli</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bal</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia.</article-title>
            <source>Respiration</source>
            <year>2008</year>
            <volume>76</volume>
            <issue>3</issue>
            <fpage>270</fpage>
            <page-range>270-4</page-range>
            <pub-id pub-id-type="pmid">18463428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of acid base balance: the theory practice relationship.</article-title>
            <source>Intensive Crit Care Nurs</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-38; quiz 38-40</page-range>
            <pub-id pub-id-type="pmid">17689248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreppein</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Litterst</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management].</article-title>
            <source>Med Klin Intensivmed Notfmed</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-201</page-range>
            <pub-id pub-id-type="pmid">26902369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiavo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Polverino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Polverino</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Acid-base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward.</article-title>
            <source>Multidiscip Respir Med</source>
            <year>2016</year>
            <volume>11</volume>
            <fpage>23</fpage>
            <pub-id pub-id-type="pmid">27226896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kayacan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Beder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Deda</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karnak</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Neurophysiological changes in COPD patients with chronic respiratory insufficiency.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-5</page-range>
            <pub-id pub-id-type="pmid">11817264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manca-Di-Villahermosa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tedesco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lonzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Della-Rovere</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Innocenzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colarieti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Favar&#x000f2;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chamoun</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Taccone-Gallucci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acid-base balance and oxygen tension during dialysis in uremic patients with chronic obstructive pulmonary disease.</article-title>
            <source>Artif Organs</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>12</issue>
            <fpage>973</fpage>
            <page-range>973-7</page-range>
            <pub-id pub-id-type="pmid">19133027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardsley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pilcher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McKinstry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shirtcliffe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fingleton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weatherall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beasley</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.</article-title>
            <source>BMC Pulm Med</source>
            <year>2018</year>
            <month>Oct</month>
            <day>03</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>157</fpage>
            <pub-id pub-id-type="pmid">30285695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Austin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Blizzard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Wood-Baker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial.</article-title>
            <source>BMJ</source>
            <year>2010</year>
            <month>Oct</month>
            <day>18</day>
            <volume>341</volume>
            <fpage>c5462</fpage>
            <pub-id pub-id-type="pmid">20959284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aubier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murciano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Milic-Emili</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pariente</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Derenne</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1980</year>
            <month>Aug</month>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-9</page-range>
            <pub-id pub-id-type="pmid">6774639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanson</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Frasch</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease.</article-title>
            <source>Crit Care Med</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-8</page-range>
            <pub-id pub-id-type="pmid">8565533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raherison</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ouaalaya</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Bernady</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casteigt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nocent-Eijnani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Falque</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le Guillou</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ozier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Molimard</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comorbidities and COPD severity in a clinic-based cohort.</article-title>
            <source>BMC Pulm Med</source>
            <year>2018</year>
            <month>Jul</month>
            <day>16</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <pub-id pub-id-type="pmid">30012144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Culver</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Assessment of severity and prognosis in COPD: moving beyond percent of predicted.</article-title>
            <source>Eur Respir J</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>52</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30072543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19969.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadatsafavi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghanbarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adibi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>FitzGerald</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Flanagan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sin</surname>
                <given-names>D</given-names>
              </name>
              <collab>Canadian Respiratory Research Network</collab>
            </person-group>
            <article-title>Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada.</article-title>
            <source>Med Decis Making</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-167</page-range>
            <pub-id pub-id-type="pmid">30678520</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
